Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
PLUS THERAPEUTICS, INC. has filed 1,439 SEC EDGAR filings since 30 Mar 2001

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
SC 13G/A File 005-80327

CYTORI

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80327

SC 13G filing

Filing date
04 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Feb 2011
Reporting date
18 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2011
Reporting date
27 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2011
Reporting date
01 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Dec 2010
Reporting date
22 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 12-6-2010

Filing date
09 Dec 2010
Reporting date
06 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34375

CYTORI THERAPEUTICS, INC. FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2010

Filing date
08 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

CYTORI THERAPEUTICS FORM 8-K FILED 11-4-2010

Filing date
04 Nov 2010
Reporting date
04 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

FORM 8-K

Filing date
03 Nov 2010
Reporting date
01 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Nov 2010
Reporting date
01 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Nov 2010
Reporting date
01 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34375

FORM 8-K

Filing date
08 Oct 2010
Reporting date
08 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-157023

PROSPECTUS SUPPLEMENT

Filing date
08 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-157023

FREE WRITING PROSPECTUS

Filing date
08 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3MEF File 333-169822

FORM S-3

Filing date
07 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-157023

FREE WRITING PROSPECTUS

Filing date
07 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .